The Turtle in Your Bloodstream

Blood, turtles, and the science your doctor can't see yet — Heliox digs into long COVID's hidden biology. 🩸🐢🧵

Here's the thing about broken bones: they're rude, but they're honest. The x-ray doesn't negotiate. It shows you the jagged white line and everybody in the room — you, the doctor, the insurance company — agrees on what happened. There's a comfort in that. Violence you can see is violence you can manage.

Long COVID doesn't offer you that mercy.

For a while now, we've been telling people with post-viral fatigue and brain fog and unexplained chest pain that we believe them, which is the medically appropriate thing to say and also, if we're honest, a slightly hollow one. Belief isn't a diagnosis. Belief doesn't get you a treatment code. And in the meantime, the numbers keep climbing in the background like a bathtub nobody's watching. In British Columbia this week, the modelling says tens of thousands of new infections. Apply the roughly one-in-three odds of developing long COVID, and you get a small city's worth of people quietly stepping into a chronic illness that their own blood tests will insist isn't there.

This is a sensitive health topic, so a brief note: nothing above and in the podcast should be read as medical advice, and anyone concerned about their own long COVID symptoms or testing options should talk to a physician.

References
Prevalence and duration of common symptoms in people with long COVID: a systematic review and meta-analysis

The Moriarty Lab at the University of Toronto is an infectious diseases research laboratory led by Dr. Tara Moriarty. COVID-19 Hazard Index
 

This is Heliox: Where Evidence Meets Empathy

Independent, moderated, timely, deep, gentle, clinical, global, and community conversations about things that matter.  Breathe Easy, we go deep and lightly surface the big ideas.

Transcript

Copy Transcript Copied

0:25

You know, usually when we talk about a medical diagnosis, there's this expectation of precision. You break your arm and the x-ray shows that jagged white line and the doctor just points and says, you know, there it is. Broken. It's binary. We inherently trust things that can be visualized and categorized instantly. But then you step into the world of post-viral syndromes, and suddenly that x-ray machine is just utterly useless. We're looking at a diagnostic landscape that is incredibly murky. Yeah, it really is. And we wanted to pull this specific stack of research together specifically for you, because, well, we know you're looking at the current infection waves and trying to understand the long-term mechanics. So today, we are going to figure out exactly how an invisible virus is essentially turning human blood into biological concrete. and why the medical system is currently completely blind to it. Ah. - That's the mission for this deep dive. And the urgency to map this out couldn't really be higher. Yeah. - Especially when you look at the raw math of our current moment. Yeah, when you actually do the math on the local infection rates, the scale becomes pretty terrifying. We are looking at sobering data from August 2026. This is straight out of the University of Toronto's Moriarty Lab. In British Columbia alone, the modeling shows there are between 25,200 and 40,500 new COVID-19 infections happening this very week. Which means roughly one in every 188 people in the province is currently infected. Wow. And that is just the acute side of the equation. We have to synthesize that local snapshot with the global prevalence data from our stack. The meta-analyses consistently show that an estimated 36% of COVID-19 positive individuals go on to develop long COVID. Okay, let's unpack this. If we take the conservative end of that BC infection estimate, so say 25,000 new infections this week, and apply that 36% prevalence rate, we are looking at 9,000 people in one province from a single week's cohort stepping into a chronic lingering epidemic. illness. It's a looming chronic health wave of just unprecedented proportions week after week. Right. So to understand what actually awaits those 9000 people, we have to turn to the primary paper in our stack today. It's called Prevalence and Duration of Common Symptoms in People with Long COVID, a Systematic Review and Meta-Analysis. And this is by a team led by Luo. Yeah. And this paper is really a masterclass in separating signal from noise. Because early in the pandemic, the definitions of long COVID were statistically chaotic. Right. They captured everything from, you know, a standard post-viral cough to completely unrelated ailments. Right. The Luo team needed undeniable hard data to truly define the syndrome. So they employed the PICIOS framework to filter the noise right. They were ruthlessly throwing out thousands of studies. Like if a study looked at symptoms lasting less than four weeks, it was out. Because you have to differentiate acute recovery from chronic pathology. Exactly. And if a study relied on a patient self-diagnosing without laboratory confirmation of their initial infection, that was out too. So they isolated 19 golden epidemiological observational studies. And by stripping away the noise, these 19 studies allowed them to see the true shape and duration of the syndrome. And what they found is heavily clustered around five pillars. Let's walk through the timeline of these because the duration data is staggering. First up is cognitive memory and attention disorders. This affects 36% of these patients. And the cognitive impairment, the severe word-finding difficulties can last a full 12 months. A whole year. Yeah. A whole year of profound neurological friction. The second pillar is fatigue, which affects 34% of patients and lasts an average of 5.5 months. And according to the 2026 Patient-Led Research Collaborative Fact Sheet in our sources, the functional ability scores for people with long COVID are on par with Parkinson's disease. I mean, the fatigue scores rank worse than end-stage kidney failure. It is a cellular level exhaustion. It's not just feeling sleepy. Right. The third pillar is mental health, so anxiety and depression. That affects 31% and lasts 3.5 to 3.8 months. Fourth is dyspnoia, or shortness of breath, hitting 24% of patients and lasting 6.5 months. And finally, chest pain, affecting 23% and lasting roughly two months. But hold on. Look at those fatigue and anxiety numbers. We live in the 2020s. Everyone is exhausted and anxious. How do we know this is a biological virus doing this and not just, I don't know, the psychological toll of the era? And that skepticism is exactly why the Lew paper's rigorous inclusion criteria were so vital. By exclusively using lab-confirmed cases and tracking specific symptom durations across massive controlled cohorts, They prove this isn't just systemic burnout. There's a distinct biological mechanism at play. It makes me think of a hurricane, the acute viral infection, you know, that initial week of fever that's the storm making landfall, it blows off some shingles. But long COVID isn't the storm, it's the black mold that quietly grows in the flooded basement for a year afterward. You can't just blame the mold on living in a damp climate. The storm breached the foundation and brought the water in. I like that. The storm breached the defenses. Yes. And to understand how that mold takes hold so effectively, we have to look at the structural biology of the virus itself. Specifically, how the newest iteration is uniquely designed to bypass our immune system's boarded up windows. Right. So let's bring in the cicada paper on the BA.3.2.1 variant. Because the virus is constantly solving the problem of our immune system. Exactly. What is remarkable about BA.3.2.1 is the evolutionary tradeoff it made. Compared to JAN.1 descendants like XCC and LP.8.1, BA.3.2.1, actually replicates slower. Oh, really? Yeah, it traded replication speed for masterful immune evasion by radically remodeling its spike protein. So normally the spike protein opens up to attach to our cells. But when it opens, it exposes vulnerable spots called epitopes to our neutralizing antibodies. So this new variant, BA.3.2.1, adopts a tightly closed, compact, locked trimer state. It does this through a very specific mutation. The virus acquired a new glycan at position 529, and this N529 glycan acts as a structural padlock. bonding to an adjacent part of the spike and locking the whole structure down. Here's where it gets really interesting. It's basically a turtle. A turtle. Yeah, it moves slower than the other variants because of that replication trade-off. But by pulling its head and legs into its shell into this closed trimer state, The immune system's predators, the antibodies, even the engineered ones like tixagevimab, they just bounce right off. They can't sink their teeth into those hidden epitopes. That structural camouflage is brilliant. But here's the terrifying speculation from the structural data. Because the entire spike structure is locked down, it binds to our ACE2 receptors less efficiently overall. Okay. But once it does manage to spring open, the individual receptor binding domain has a remarkably high affinity for human cells. It binds incredibly tightly. It is a patient, highly efficient infiltrator that waits, hides. And once it strikes, it doesn't let go. Wow. So the turtle gets past the immune system and infects the body. But how does that respiratory infection leave behind the biological mold? How do we bridge the gap between this clever little virus and the six-month-long fatigue or the 12-month brain fog that was documented in the LUO paper? Well, that bridge is found in the blog. We're looking at research from Henrik Westman's team at Linköping University in Sweden and Itherhysia pretorius and Douglas Kell's team in South Africa. Right. And they converged on a fundamental terrifying discovery. The spike protein is amyloidogenic. Meaning that when this protein breaks apart, it causes other proteins around it to misfold into dense, tangled clumps. Yes. Westman's team mapped the exact biochemistry of this. When the immune system fights the virus, it deploys enzymes like neutrophil elastase to chop up the invading pathogen. Right, to clear it out. But they found that one specific cleaved fragment of the spike protein, called spike 685, which is located right after the furin cleavage site, It does something incredibly dangerous when circulating in the plasma. So wait, the immune system's own weapon, the elastase meant to clear the debris, is what accidentally triggers the cascade. Because that spike 685 fragment interacts with fibrinogen. And when fibrinogen interacts with spike 685, it panics. It folds incorrectly into chaotic amyloid fibrils. And this severely disrupts the body's natural plumbing system. Normal clots are broken down by a process called plasmin-mediated fibrinolysis. Right. But the plasmin cannot break down these spike-induced amyloid clots. They resist fibrinolysis completely. They're, as you said earlier, biological concrete. If we connect this to the bigger picture, this connects the entire Luo paper for me. If my microcapillaries are clogged with concrete, oxygen literally cannot reach my tissues. So the 36% of people with cognitive issues for a year, their brain tissue is being micro-suffocated. Exactly. The 34% with fatigue worse than kidney failure, the capillaries feeding their muscles are blocked, the virus is long gone, but the concrete remains in the plumbing starving the body of oxygen on a micro-suffocator. level. It completely takes long COVID out of the psychological realm and firmly into the physical vascular realm. The mechanisms for the dyspnoea and the chest pain are the exact same. It's microclotting in the pulmonary and cardiac microvasculature. OK, but if my capillaries are literally clogged with amyloid concrete, why on earth is my doctor telling me my D-dimer blood test is? completely normal. Well, because a D-dimer test looks for the breakdown products of normal clots. Oh. Yeah, since these animal clots don't break down, the standard tests are completely blind to them. The concrete isn't dissolving, so there's no debris for the D-dimer to detect. So there's literally nothing for the test to see. Right. So how do we actually prove a patient has this? I mean, the Pretorius and Kel paper details this incredibly frustrating diagnostics dead end that they had to navigate for. They initially used fluorescence microscopy. They added theoflavin T, which is a dye that binds specifically to misfolded amyloid proteins. They added that to patient blood plasma and looked through a microscope. They saw the glowing microclots. So that proved the concept. But as a clinical diagnostic tool, human eyes looking through a microscope at a single drop of blood is subjective. Yeah. It's agonizingly slow and lacks the statistical robustness needed to diagnose millions of people. You can't scale a researcher squinting through a lens. You need a machine. Exactly. And their breakthrough was adapting imaging flow cytometry, specifically the amnest flow cytometry. They took that same theoflavin T protocol, but instead of putting it on a slide, they ran the fluid through the flow cytometer. Instead of a human looking at a drop, this machine forces the blood into a microscopic single file stream and blasts it with lasers. It analyzes thousands of cells and particles per second, capturing an actual image of every single glowing microclot and measuring its exact size and density. Yeah, it completely removes the human bias. The machine just counts the concrete. That's incredible. And the resulting data is undeniable. The flow cytometer revealed a vastly different area distribution in long COVID patients compared to healthy controls. They don't just have more clots. They have massive, highly fluorescent, complex amyloid structures that simply do not exist in healthy blood. Reading this paper, this feels like the holy grail. It is a biological quantitative test that proves the brain fog and fatigue are physical, not psychological. But if this test is so perfect and the protocol is fully published, why can't the 40,000 people getting infected in British Columbia this week just go to their local lab and get a flow cytometry test? Because of a deeply entrenched friction in modern medicine known as the Valley of Death. Which brings us to the Zoe Slope Morris paper on translational research. The 17-year waiting room. Yes. Morris's research synthesizes a grim reality. On average, it takes 17 years for a proven scientific discovery at the bench to become standard clinical practice in a hospital. 17 years. Yeah, you had to navigate replication studies. And the Health Canada document in our stack confirms this perfectly. As of August 2026, Health Canada has not approved imaging flow cytometry or flow clotometry for long COVID. It remains strictly investigational, locked in the research labs. So the physiological mechanism is solved, but the clinical workflow is trapped in amber. Wait, 17 years? So the people in BC developing long COVID right now might have to wait until 2043 for standard clinical testing? That is unacceptable. So what does this all mean for us right now? If the medical system is 17 years behind the science and we have zero immediate medical diagnostics for these microclots, our entire strategy has to pivot to prevention. We have to stop the turtle from getting into the basement. Which is the exact premise of Petition 451-000547. Since the virus is an airborne amyloidogenic pathogen and we cannot easily test for or treat the resulting vascular damage, the focus must shift to upgrading building ventilation. The petition demands adherence to AHHRA Standard 241 for the control of infectious aerosols. We don't drink water with cholera in it. We engineered water treatment plants. Now the science is screaming at us that we have to treat indoor air the exact same way we treat drinking water. Upgrading HVACI systems and adhering to HHA 241 are no longer just facilities management issues. They are frontline primary health care interventions. Keeping the air clean is infinitely faster and cheaper than waiting 17 years for the medical system to figure out how to count the concrete in our veins. Right. So we've gone from Luo's rigorous mapping of the months-long symptoms to the BA.3.2.1 turtle shell evasion to the immune system accidentally creating amyloid concrete with the spike 685 fragment all the way to the 17-year valley of death that makes clean air our only immediate. It is a profound chain of causality. And to close this out, I want to leave you with one final data point from the 2026 fact sheet to mull over. The data clearly shows that reinfection compounds the risk. A Canadian cohort study showed that a 1.7 times higher risk of long COVID after two infections, and a 2.6 times higher risk after three. Because for the last few years, society has largely treated each infection like a fresh roll of the dice. You get a cold, you get over it, your slate is wiped clean. But if this virus actively leaves behind undissolvable biological concrete, is the slate ever truly wiped clean? Or is every single infection a cumulative deposit slowly building up in your capillaries, just waiting for the dam to break? We started this deep dive talking about the comfort of an x-ray of seeing exactly what is broken. And it turns out the scariest thing isn't the damage we can't see right now. The scariest thing is the damage that is slowly accumulating layer by layer while we wait for the tools to finally look at it. Thank you so much for joining us on this deep dive. Stay curious and we'll catch you next time.